Suboxone Tooth Decay

What the lawsuit is about

Lawsuits allege that Suboxone film or tablets may be linked to severe tooth decay and that warnings about dental risks were not adequate for some users.

Claims may involve Suboxone medication-assisted treatment products. Plaintiffs claim they experienced injuries after use or exposure, while defendants generally dispute allegations, causation, liability, or damages. No page on this site can determine whether a person qualifies for a claim.

Suboxone Tooth Decay Lawsuit Update: May 2026

Suboxone dental injury claims appear active and are being handled through coordinated federal litigation. Federal Suboxone film product liability cases are centralized in MDL No. 3092 in the Northern District of Ohio, where the court is managing common pretrial issues involving warnings, product form, dental injury allegations, and case-specific proof.

As of May 2026, the litigation appears more active and pretrial-focused than settlement-focused. The major current issues include whether oral buprenorphine/naloxone products contributed to severe dental injuries, whether warnings were adequate, whether a person's dental records show a meaningful before-and-after pattern, and how other dental risk factors should be considered.

Recent public updates continue to focus on MDL management, discovery, claim screening, and dental-record documentation. For people researching the case, this means that product history and dental history are central: pharmacy records, treatment program records, dental charts, X-rays, extraction records, and restoration invoices may all matter.

Case Status Snapshot

• Status: Active / Investigating
• Primary injury: Severe dental injuries, including tooth decay, tooth loss, and extractions
• Main product/exposure: Suboxone film and other oral buprenorphine/naloxone products dissolved in the mouth
• MDL or court context: MDL No. 3092, Northern District of Ohio
• Settlement status: No confirmed global personal-injury settlement; litigation remains in active pretrial development
• Key deadline: Varies by state, injury date, discovery facts, warning timeline, and individual circumstances
• State law relevance: State law may affect filing deadlines, warning claims, damages, comparative fault, and medical-expense proof

Litigation Updates and Timeline

• January 2022: The FDA warned that dental problems had been reported with medicines containing buprenorphine that dissolve in the mouth and required new warning information.
• February 2024: The JPML centralized federal Suboxone film product liability cases in MDL No. 3092 in the Northern District of Ohio.
• 2025: MDL activity focused on pleadings, discovery, case organization, and procedures for handling common warning and dental-injury issues.
• Early 2026: Public litigation updates continued to focus on discovery, case management, and identifying claims with adequate prescription and dental documentation.
• May 2026: Claims remain active, with the practical focus on product history, dental records, injury timing, and state-law deadline issues.

Current litigation status

Suboxone dental injury claims are active and are being evaluated in coordinated federal litigation. Federal Suboxone film product liability cases have been centralized in MDL No. 3092 in the Northern District of Ohio for pretrial proceedings involving common issues such as warnings, product design, dental injury allegations, and case management.

The litigation focuses on allegations that Suboxone film or related oral buprenorphine/naloxone products contributed to severe dental problems and that users were not adequately warned about the risk. Defendants generally dispute causation, warning, liability, and damages issues. Litigation status can change, so this guide is a general overview rather than a live docket report.

Key issues in the lawsuit

Suboxone tooth decay lawsuits generally involve allegations that oral Suboxone products dissolved in the mouth exposed teeth and gums to conditions that contributed to decay, erosion, cavities, gum problems, tooth loss, extractions, and costly dental restoration. These claims often focus on Suboxone film, although some people may have histories involving tablets or other buprenorphine/naloxone products.

The key questions include whether the product’s formulation and method of use could contribute to dental injury, whether warnings were adequate at the time the person used the medication, whether dental problems began or worsened after use, and whether other factors explain the injury. The cases also involve sensitive medical context because Suboxone is used in medication-assisted treatment. A neutral claim review should separate the legal product-warning questions from stigma about substance use treatment.

Defendants may argue that dental decay is common, that a user had preexisting dental problems, that oral hygiene or dry mouth contributed to the injury, or that warnings and prescribing information were adequate. Plaintiffs may respond by pointing to dental records before and after use, documented product history, and the timing or severity of dental deterioration.

How claims may be evaluated

A Suboxone claim review often starts with product history. Prescription records, pharmacy records, treatment program records, medication-assisted treatment notes, insurance records, and provider records may show when Suboxone was prescribed, what form was used, and how long use continued. The specific product matters because different formulations, routes of administration, and warning histories may be evaluated differently.

Dental records are central. A lawyer may ask for dental charts, X-rays, periodontal records, treatment plans, extraction records, crown or implant invoices, denture records, photographs, and records showing dental condition before and after Suboxone use. If a person did not see a dentist regularly before the injury, other records may still help, but the evaluation may be more difficult.

Causation review may consider when tooth pain, cavities, gum problems, breakage, or extractions began; whether dental problems accelerated after product use; whether the user had dry mouth, reflux, diabetes, smoking history, other medications, or other risk factors; and whether dentists documented unusual or severe decay patterns.

Common fact patterns

One common fact pattern may involve a person who used Suboxone film daily for months or years as part of treatment and later experienced rapid decay, multiple cavities, broken teeth, extractions, or a need for dentures, bridges, crowns, implants, or other restoration. Another may involve a person who had manageable dental issues before treatment but developed widespread dental problems after a period of regular oral Suboxone use.

Some people may have pharmacy histories showing regular fills and dental records showing a sharp change in dental condition. Others may have treatment program records but limited dental documentation. A clearer timeline can help show whether dental injury appeared after product use and whether the pattern was severe enough to warrant legal review.

Costs may also matter. Dental repair can involve repeated visits, treatment plans, extractions, temporary appliances, permanent restoration, and out-of-pocket expenses. These records may help show the scope of alleged damages, but they do not guarantee that a claim will be accepted.

What can make a claim harder to evaluate

Suboxone claims can be harder to review when there are no prescription records, unclear product form, uncertain dates of use, or little dental history before the alleged injury. Missing dental records may make it difficult to compare a person’s condition before and after use.

Alternative explanations can also complicate causation. Longstanding dental disease, limited access to dental care, dry mouth from other medications, smoking, diabetes, reflux, diet, prior substance use, or delayed treatment can all become issues in claim evaluation. These facts do not automatically defeat a claim, but they may need to be addressed honestly.

Deadline issues may also be important. The date a person first experienced dental injury, first learned of a possible product connection, or first received a warning may matter differently depending on state law. Prior releases or settlement agreements involving related medical care may also require review.

Why state law may still matter

National coordination can help manage common discovery and pretrial issues, but state law can still affect individual claims. Filing deadlines, discovery rules, damages law, warning standards, comparative fault rules, and medical-expense proof can vary by state.

For Suboxone dental claims, state law may affect how courts evaluate when a person should have discovered a possible connection between the medication and dental injury. It may also affect wrongful death or estate issues in rare cases where broader medical complications are involved. A lawyer would need to review the person’s state, treatment history, and timeline before giving legal advice.

Questions to ask before contacting a lawyer

• Which Suboxone product did I use: film, tablet, or another form?
• Do I have pharmacy or treatment program records showing dates of use?
• Do my dental records show my condition before and after use?
• What dental work was recommended or completed, and what did it cost?
• When did I first notice tooth decay, tooth loss, or gum problems?
• How could state filing deadlines affect a dental injury claim?

Sources and status notes

• Federal court context: Federal Suboxone tooth decay cases have been coordinated in multidistrict litigation for common pretrial issues. The JPML transfer materials for MDL No. 3092 describe the coordinated federal proceeding.
• Agency or medical context: Claim review may involve prescription records, dental records, pharmacy records, warnings, and records showing tooth decay, extractions, or restorative treatment. The FDA has published a buprenorphine dental-problems safety communication for medicines dissolved in the mouth.
• Litigation status: This guide summarizes public litigation status information and should not be treated as a live court docket. The litigation remains active, and individual review may depend on use history, dental injury records, and timing.
• Review note: Case status, settlement posture, deadlines, and eligibility factors can change.
• Last reviewed: May 23, 2026.

Who may be affected

• People with documented use of or exposure to Suboxone medication-assisted treatment products.
• People later diagnosed with severe dental injuries.
• People who can identify approximate dates, locations, providers, employers, or exposure circumstances.
• Families evaluating possible wrongful death issues should ask a lawyer how state law may apply.

Injuries involved

• Severe tooth decay
• Tooth loss
• Cavities
• Dental extractions
• Gum damage
• Dental restoration costs

Evidence usually needed

• Prescription records
• Treatment program records
• Dental records before and after use
• Extraction records
• Restoration invoices
• Photographs or dental imaging

Timeline

Settlement status

Suboxone dental injury litigation appears to be in an active pretrial and claim-evaluation stage. No global personal-injury settlement is guaranteed or confirmed here. Settlement posture may depend on discovery, warnings evidence, product-form evidence, dental-record proof, bellwether planning, and rulings about causation and limitations issues. People researching a possible claim should avoid settlement calculators and focus on prescription history, dental records, treatment costs, and the date dental injuries were first discovered.

Deadline overview

Deadlines vary by state and may depend on diagnosis date, discovery date, exposure history, wrongful death issues, and other facts. A lawyer can evaluate how the relevant deadline rules may apply.

State-by-state guide links